HomeNDC LookupRxCUI directory › RxCUI 197943

Methocarbamol 500 MG Oral Tablet — RxCUI 197943

RxNorm drug concept · Semantic clinical drug
RxCUI 197943 Semantic clinical drug · SCD ● Current RxNorm concept 128 FDA products 431 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197943
Official nameMethocarbamol 500 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped128
Package NDCs mapped431
Reported Medicaid activity (SDUD)1,310,003 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methocarbamol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Methocarbamol is a muscle relaxant that works through your central nervous system — your brain and spinal cord — rather than directly on the muscles themselves. It's thought to red...
  • What exactly does methocarbamol do? Will it make my muscles stop hurting?
  • You really should not. Methocarbamol already causes drowsiness and slows your central nervous system down. Adding alcohol on top of that significantly increases those effects — we'...
  • Be careful, especially when you first start taking it. Methocarbamol can impair your alertness, coordination, and reaction time. Don't drive or operate heavy machinery until you kn...
📖 Read our full Methocarbamol guide →

🕸️ Concept Web — How Methocarbamol 500 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Methocarbamol 500 MG Oral Tablet RxCUI 197943

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Methocarbamol 6845
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Robaxin 202955
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methocarbamol Oral Tablet 372831
    • Methocarbamol Oral Product 1162231
    • Methocarbamol Pill 1162232
    • Methocarbamol Oral Tablet [Robaxin] 368800
    • Robaxin Oral Product 1185926
    • Robaxin Pill 1185927
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Methocarbamol 500 MG 316274
    • Methocarbamol 500 MG Oral Tablet [Robaxin] 207016
    • Methocarbamol 500 MG [Robaxin] 567812

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Methocarbamol 500 MG SCDC · 316274
  • Methocarbamol Oral Tablet SCDF · 372831
  • Methocarbamol Oral Product SCDG · 1162231
  • Methocarbamol Pill SCDG · 1162232

Brand-Name Concepts

  • Methocarbamol 500 MG Oral Tablet [Robaxin] SBD · 207016
  • Methocarbamol 500 MG [Robaxin] SBDC · 567812
  • Methocarbamol Oral Tablet [Robaxin] SBDF · 368800
  • Robaxin Oral Product SBDG · 1185926
  • Robaxin Pill SBDG · 1185927
  • Robaxin BN · 202955

📦 FDA Products & Package NDCs

128 products · 431 package NDCs
431 package NDCs map to RxCUI 197943 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
76420-0894-90 90 TABLET, COATED in 1 BOTTLE (76420-894-90) Methocarbamol Asclemed USA, Inc. 2025-01-28
80425-0138-01 60 TABLET, FILM COATED in 1 BOTTLE (80425-0138-1) Methocarbamol Advanced Rx Pharmacy of Tennessee, LLC 2018-01-15
80425-0138-02 90 TABLET, FILM COATED in 1 BOTTLE (80425-0138-2) Methocarbamol Advanced Rx Pharmacy of Tennessee, LLC 2018-01-15
80425-0275-01 30 TABLET in 1 BOTTLE (80425-0275-1) Methocarbamol Advanced Rx Pharmacy of Tennessee, LLC 2023-02-17
80425-0275-02 60 TABLET in 1 BOTTLE (80425-0275-2) Methocarbamol Advanced Rx Pharmacy of Tennessee, LLC 2023-02-17
80425-0275-03 90 TABLET in 1 BOTTLE (80425-0275-3) Methocarbamol Advanced Rx Pharmacy of Tennessee, LLC 2023-02-17
80425-0283-01 30 TABLET in 1 BOTTLE (80425-0283-1) Methocarbamol Advanced Rx Pharmacy of Tennessee, LLC 2023-03-07
80425-0283-02 60 TABLET in 1 BOTTLE (80425-0283-2) Methocarbamol Advanced Rx Pharmacy of Tennessee, LLC 2023-03-07
80425-0283-03 90 TABLET in 1 BOTTLE (80425-0283-3) Methocarbamol Advanced Rx Pharmacy of Tennessee, LLC 2023-03-07
80425-0283-04 120 TABLET in 1 BOTTLE (80425-0283-4) Methocarbamol Advanced Rx Pharmacy of Tennessee, LLC 2023-03-07
80425-0283-05 180 TABLET in 1 BOTTLE (80425-0283-5) Methocarbamol Advanced Rx Pharmacy of Tennessee, LLC 2023-03-07
80425-0577-01 30 TABLET in 1 BOTTLE (80425-0577-1) Methocarbamol Advanced Rx of Tennessee, LLC 2026-02-18
80425-0577-02 60 TABLET in 1 BOTTLE (80425-0577-2) Methocarbamol Advanced Rx of Tennessee, LLC 2026-02-18
80425-0577-03 90 TABLET in 1 BOTTLE (80425-0577-3) Methocarbamol Advanced Rx of Tennessee, LLC 2026-02-18
80425-0577-04 120 TABLET in 1 BOTTLE (80425-0577-4) Methocarbamol Advanced Rx of Tennessee, LLC 2026-02-18
80425-0577-05 180 TABLET in 1 BOTTLE (80425-0577-5) Methocarbamol Advanced Rx of Tennessee, LLC 2026-02-18
80425-0578-01 30 TABLET, COATED in 1 BOTTLE (80425-0578-1) Methocarbamol Advanced Rx of Tennessee, LLC 2026-03-13
80425-0578-02 60 TABLET, COATED in 1 BOTTLE (80425-0578-2) Methocarbamol Advanced Rx of Tennessee, LLC 2026-03-13
80425-0578-03 90 TABLET, COATED in 1 BOTTLE (80425-0578-3) Methocarbamol Advanced Rx of Tennessee, LLC 2026-03-13
80425-0578-04 120 TABLET, COATED in 1 BOTTLE (80425-0578-4) Methocarbamol Advanced Rx of Tennessee, LLC 2026-03-13
80425-0578-05 180 TABLET, COATED in 1 BOTTLE (80425-0578-5) Methocarbamol Advanced Rx of Tennessee, LLC 2026-03-13
80425-0578-06 12 TABLET, COATED in 1 BOTTLE (80425-0578-6) Methocarbamol Advanced Rx of Tennessee, LLC 2026-03-13
80425-0579-01 30 TABLET, COATED in 1 BOTTLE (80425-0579-1) Methocarbamol Advanced Rx of Tennessee, LLC 2025-03-25
80425-0579-02 60 TABLET, COATED in 1 BOTTLE (80425-0579-2) Methocarbamol Advanced Rx of Tennessee, LLC 2025-03-25
80425-0579-03 90 TABLET, COATED in 1 BOTTLE (80425-0579-3) Methocarbamol Advanced Rx of Tennessee, LLC 2025-03-25
80425-0579-04 120 TABLET, COATED in 1 BOTTLE (80425-0579-4) Methocarbamol Advanced Rx of Tennessee, LLC 2025-03-25
80425-0579-05 180 TABLET, COATED in 1 BOTTLE (80425-0579-5) Methocarbamol Advanced Rx of Tennessee, LLC 2025-03-25
80425-0579-06 12 TABLET, COATED in 1 BOTTLE (80425-0579-6) Methocarbamol Advanced Rx of Tennessee, LLC 2025-03-25
82804-0121-30 30 TABLET in 1 BOTTLE (82804-121-30) Methocarbamol Proficient Rx LP 2024-07-23
82804-0121-90 90 TABLET in 1 BOTTLE (82804-121-90) Methocarbamol Proficient Rx LP 2024-07-11
82804-0273-30 30 TABLET in 1 BOTTLE (82804-273-30) Methocarbamol Proficient Rx LP 2026-03-13
82804-0273-90 90 TABLET in 1 BOTTLE (82804-273-90) Methocarbamol Proficient Rx LP 2026-03-13
82804-0954-00 100 TABLET in 1 BOTTLE (82804-954-00) Methocarbamol Proficient Rx LP 2026-01-12
82804-0954-30 30 TABLET in 1 BOTTLE (82804-954-30) Methocarbamol Proficient Rx LP 2026-01-12
82804-0954-55 500 TABLET in 1 BOTTLE (82804-954-55) Methocarbamol Proficient Rx LP 2026-01-12
82804-0954-60 60 TABLET in 1 BOTTLE (82804-954-60) Methocarbamol Proficient Rx LP 2026-01-12
82804-0954-72 120 TABLET in 1 BOTTLE (82804-954-72) Methocarbamol Proficient Rx LP 2026-01-12
82804-0954-90 90 TABLET in 1 BOTTLE (82804-954-90) Methocarbamol Proficient Rx LP 2026-01-12
82804-0955-00 100 TABLET in 1 BOTTLE (82804-955-00) Methocarbamol Proficient Rx LP 2026-01-12
82804-0955-30 30 TABLET in 1 BOTTLE (82804-955-30) Methocarbamol Proficient Rx LP 2026-01-12
82804-0955-55 500 TABLET in 1 BOTTLE (82804-955-55) Methocarbamol Proficient Rx LP 2026-01-12
82804-0955-60 60 TABLET in 1 BOTTLE (82804-955-60) Methocarbamol Proficient Rx LP 2026-01-12
82804-0955-72 120 TABLET in 1 BOTTLE (82804-955-72) Methocarbamol Proficient Rx LP 2026-01-12
82804-0955-90 90 TABLET in 1 BOTTLE (82804-955-90) Methocarbamol Proficient Rx LP 2026-01-12
85509-1910-01 100 TABLET in 1 BOTTLE (85509-1910-1) Methocarbamol PHOENIX RX LLC 2025-07-11
85509-1910-03 30 TABLET in 1 BOTTLE (85509-1910-3) Methocarbamol PHOENIX RX LLC 2025-11-11
85509-1910-06 60 TABLET in 1 BOTTLE (85509-1910-6) Methocarbamol PHOENIX RX LLC 2025-07-14
85509-1910-09 90 TABLET in 1 BOTTLE (85509-1910-9) Methocarbamol PHOENIX RX LLC 2025-07-14
85509-2910-01 100 TABLET in 1 BOTTLE (85509-2910-1) Methocarbamol PHOENIX RX LLC 2026-02-13
85509-2910-03 30 TABLET in 1 BOTTLE (85509-2910-3) Methocarbamol PHOENIX RX LLC 2026-02-13
Observed labelers: Bryant Ranch Prepack (80) · Proficient Rx LP (44) · Asclemed USA, Inc. (36) · PD-Rx Pharmaceuticals, Inc. (32) · A-S Medication Solutions (27) · Aphena Pharma Solutions - Tennessee, LLC (18) · +41 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.